Search results
Objective Capital Management LLC Grows Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)
ETF DAILY NEWS· 6 days agoObjective Capital Management LLC lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 30.1% during the fourth quarter, according to its most recent disclosure with the ...
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo Finance· 3 days agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 3 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...
Gateway - Quartz
Quartz· 4 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 4 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
Gateway - Quartz
Quartz· 5 days agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 5 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
SageView Advisory Group LLC Has $3.66 Million Stock Holdings in Innovator U.S. Equity Ultra Buffer...
ETF DAILY NEWS· 6 days agoSageView Advisory Group LLC grew its stake in Innovator U.S. Equity Ultra Buffer ETF – April...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 6 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report) , Novavax and ...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 3 days agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
